Fate Therapeutics (FATE)
NASDAQ:FATE
Holding FATE?
Track your performance easily

Fate Therapeutics (FATE) Financial Statements

1,126 Followers

Fate Therapeutics Financial Overview

Fate Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.707; its P/E ratio is -1.42; Fate Therapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 6.77M$ 1.93M$ 1.68M$ 1.94M$ 933.00K
Gross Profit$ 6.77M$ 1.93M$ 1.68M$ 1.94M$ 933.00K
EBIT$ -38.43M$ -46.61M$ -48.08M$ -51.28M$ -52.76M
EBITDA$ -31.07M$ -44.42M$ -43.19M$ -46.54M$ -45.99M
Net Income Common Stockholders$ -38.43M$ -48.00M$ -44.12M$ -45.17M$ -52.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 304.88M$ 383.54M$ 315.18M$ 349.73M$ 377.94M
Total Assets$ 528.82M$ 569.89M$ 506.22M$ 543.79M$ 584.76M
Total Debt$ 100.56M$ 102.07M$ 103.54M$ 104.95M$ 106.35M
Net Debt$ -204.32M$ -281.47M$ -211.64M$ -244.78M$ -271.59M
Total Liabilities$ 131.84M$ 143.78M$ 137.80M$ 141.01M$ 147.00M
Stockholders Equity$ 396.98M$ 426.12M$ 368.42M$ 402.78M$ 437.75M
Cash Flow-
Free Cash Flow$ -32.36M$ -33.44M$ -36.82M$ -38.84M$ -30.69M
Operating Cash Flow$ -32.31M$ -33.35M$ -36.64M$ -38.27M$ -28.49M
Investing Cash Flow$ -53.37M$ 17.31M$ 45.35M$ 24.80M$ 33.17M
Financing Cash Flow$ 1.27M$ 95.49M$ -180.00K-$ 58.00K
Currency in USD

Fate Therapeutics Earnings and Revenue History

Fate Therapeutics Debt to Assets

Fate Therapeutics Cash Flow

Fate Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis